Calamos Advisors
XENT

Calamos Advisors’s Intersect ENT, Inc XENT Stock Holding History

Calamos Advisors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-219,732
Closed -$6.16M – 1256
2022
Q1 		$6.16M Buy
219,732
+17,346
+9% +$475K 0.02% 641
2021
Q4 		$5.53M Buy
+202,386
New +$5.49M 0.02% 658

Calamos Advisors's XENT Position: Q2 2022 in Review

Calamos Advisors sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 219,732 shares — an estimated $6.16M sold.

Calamos Advisors first reported a position in XENT in Q4 2021 and held it in 2 quarters. The position peaked at $6.16M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Calamos Advisors reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Calamos Advisors sold 219,732 Intersect ENT, Inc shares in Q2 2022, an estimated $6.16M.
  • Calamos Advisors first reported a position in Intersect ENT, Inc in Q4 2021 and held it in 2 quarters.
  • Calamos Advisors's Intersect ENT, Inc position peaked at $6.16M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Calamos Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.